Clearance Summary
Bunkerhill ECG-EF received FDA 510(k) clearance under submission number K250649, sponsored by BunkerHill Health. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2025-09-19.
- Submission: K250649
- Applicant / Sponsor: BunkerHill Health
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2380
- Decision date: 2025-09-19
Classification & Regulation
This clearance is catalogued under FDA product code QYE and 21 CFR 870.2380, within the Cardiovascular review panel as a Class II device.